PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $80,416 | -47.6% | 25,529 | -51.6% | 0.00% | -50.0% |
| Q2 2020 | $153,578 | +3.2% | 52,776 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $148,828 | -39.7% | 52,776 | -30.6% | 0.00% | -33.3% |
| Q4 2019 | $246,623 | +50.2% | 76,001 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $164,162 | -31.2% | 76,001 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $238,643 | -15.6% | 76,001 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $282,724 | +28.3% | 76,001 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $220,403 | +10.3% | 76,001 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $199,883 | +12.3% | 76,001 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $178,000 | +44.7% | 76,001 | +81.3% | 0.00% | +100.0% |
| Q1 2018 | $123,000 | -42.0% | 41,923 | -45.9% | 0.00% | -50.0% |
| Q4 2017 | $212,000 | – | 77,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |